Home/ Supplements/ Electrolytes/ Flexezy-ER

Flexezy-ER

product on market Other (e.g. tea bag) Physician's Signature Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Calcium and phosphorus provide essential structural support for bone mineralization, with strong evidence supporting their role in skeletal health. The Flexezy proprietary blend has limited documented evidence regarding its specific efficacy. Overall, the ingredient profile focuses on foundational minerals for bone maintenance.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Flexezy-ER
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Caplet(s)
Serving Size
60
Servings
Other Combinations
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calcium
80 mg (6% DV)
60 mg (5% DV)
Within RDA (0.1× RDA) 13 studies (A:0, B:3)
Flexezy Proprietary Blend
660 mg

Other Ingredients

Dicalcium Phosphate Hydroxypropyl Methylcellulose Microcrystalline Cellulose Hypromellose Propylene Glycol Titanium Dioxide Stearic Acid Magnesium Stearate Silicon Dioxide
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take two caplets in the morning and two caplets in the evening or as directed by your healthcare provider until results are achieved. Thereafter, you may continue the above serving or decrease to one caplet in the morning and one in the evening. Caplets may be taken with or without food.

Warnings & Precautions

Caution: For adults only.

Consult your physician prior to using this product if you are pregnant, nursing or have any pre-existing conditions.

Keep out of the reach of children

Do not use if seal is broken

Contains: Crustacean shellfish (crab & shrimp).

Formulation Notes

Each Flexezy-ER caplet is made to slowly release glucosamine and chondroitin over a 12 hour period.

Extended release glucosamine and chondroitin sulfate

Not suitable for vegans.

Additional Information

Store in a cool, dry place

Metadata

Product Details

UPC / SKU8 54755 00725 4
DSLD Entry Date2024-10-24
Product TypeOther Combinations
FormOther (e.g. tea bag)
DSLD ID316960
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.